IssuerAnnouncementDetailsV2Portlet

Actions

Jamjoom Pharmaceuticals Factory Co. announces its intention to release its second quarter financial results for the period ended 30 June 2024 on Tuesday, August 6, 2024, before the trading session begins on the Saudi Exchange

4015
JAMJOOM PHARMA
-0.11 %
1446/01/12     18/07/2024 08:08:21

Element ListExplanation
Announcement Detail Jamjoom Pharmaceuticals Factory Co. will announce its 2nd Quarter 2024 results before the trading session begins on the Saudi Exchange on Tuesday, August 6, 2024, and will host its earnings call on the same day at 3pm KSA time after the close of the trading session to discuss the financial results of the 2nd Quarter of 2024 with its investors and analysts.

To register for the event, please use the link provided in the attached document.

The presentation for the earnings call will be uploaded on the investor relations webpage on Jamjoom Pharma’s website at the following link:

http://investors.jamjoompharma.com/

For inquiries, please contact the Investor Relations department through:

ir@jamjoompharma.com

Attached Documents  

The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.

Company Performance

JAMJOOM PHARMA
Add To Watchlist
In your Watchlist
Add To Watchlist
Key Parameters
Last Price 174.4
Net Change -0.2 (-0.11%)
Value Traded (Sar) 8,115,598.6
Volume Traded 46,398
See The Company Profile

LoginPortletPopupv2

Actions

AddtoWatchlistv2

Actions
NO PORTLET SESSION YET